Laying the foundations for success with scale-down models

Cell & Gene Therapy Insights 2022; 8(3), 431

10.18609/cgti.2022.062

Published: 15 April 2022
FastFacts

Watch the video or read the poster for insights into:

  • The driving challenges in cell-based therapy development and manufacturing
  • Navigating complexity while saving on costs
  • Managing complexity of scale-down models
  • Exploration of process knowledge

Rohit Saklecha is a Process Manager with experience in research & development for stem cell therapies. Rohit has over 7 years of experience working with stem cells from many different sources prior to joining Sartorius. He was most recently a Research Scientist at Intrexon working on pushing the boundaries for stem cell therapy. 

Andres Castillo is a Process Manager with experience in autologous manufacturing of CAR-T therapies. With over 8 years of gene editing experience prior to joining Sartorius, Andres was most recently a Research Scientist at Seattle Children's Hospital working in CAR-T manufacturing.